Invea Therapeutics Appoints Mr. Jason Fenton to Its Board

- Mr. Fenton augments board expertise as the Company readies for Phase 1b/2 execution of lead program targeting mast cell biology - Company also primed to...

Related Keywords

,Demetrios Kydonieus ,Kerrie Brady ,Anita Ganjoo ,Jonathan Zalevsky ,Jason Fenton ,Vimal Mehta ,Krishnan Nandabalan ,Nektar Therapeutics Inc ,Linkedin ,Twitter ,Bioxcel Therapeutics Inc ,Research Development ,Oppenheimer Co ,Invea Therapeutics Inc ,Corporate Communications ,Ocuterra Therapeutics Inc ,Healthcare Equity Capital Markets ,Healthcare Capital Markets ,Confidentially Marketed Public Offerings ,Follow On Financings ,Invea Therapeutics ,Chief Executive Officer ,Ocuterra Therapeutics ,Bioxcel Therapeutics ,Chief Research ,Development Officer ,Nektar Therapeutics ,Drug Discovery ,Gastrointestinal ,Artificial Intelligence ,Hepatology ,Inflammatory Disease ,Inflammasome ,Mast Cell ,